Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1990
06/23/1990CA2005214A1 Phosphinic acid substituted steroids as inhibitors of steroid 5–-reductase
06/23/1990CA2005165A1 Phosphonic acid substituted steroids as steroid 5.alpha.-reductase inhibitors
06/23/1990CA2004946A1 Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5–-reductase
06/22/1990CA2006353A1 Monoclonal antibody to human carcinomas
06/20/1990EP0374095A2 Piperidine derivatives
06/20/1990EP0373994A1 Mutants of simian transforming growth factor-beta 1
06/20/1990EP0373891A2 Anti-tumour agents
06/20/1990EP0373663A2 Castanospermine esters in the inhibition of tumor metastasis
06/20/1990EP0373658A2 Use of quinoline derivatives in treating cancer
06/20/1990EP0373623A2 Pharmaceutical compositions useful in potentiating natural killer cell activity
06/20/1990EP0373335A2 Serine protease inhibitor proteins, medicaments containing them, DNA sequences coding for these proteins and methods for producing these proteins, medicaments and DNA sequences
06/20/1990CN1043131A Pentacyclic triterpenoid compounds as toposomerase inhibitors or cell differentiation inducers
06/20/1990CA2005985A1 Deoxy-2 ribonucleoside derivatives and their applications
06/19/1990US4935543 Physiologically active substance tan-931, its derivatives, their production and use
06/19/1990US4935520 Compound, oleyl-2-pyridinioethyl phosphate having antifungal and antiprotozoal properties
06/19/1990US4935498 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
06/19/1990US4935445 Method for treatment tumors sensitive to treatment with anti-tumor agents employing Norverapamil
06/19/1990US4935437 (Substituted aralkyl) heterocyclic compounds
06/19/1990US4935415 Bactericides, anticarcinogenic agents
06/19/1990US4935404 Phosphorus containing peptides, pharmaceutical compositions and method of treating collagenolytic conditions
06/19/1990US4935233 Covalently linked polypeptide cell modulators
06/19/1990CA1270600A1 3-(4'-aminobutylamino)propylaminobleomycin derivatives, and processes of the preparation thereof
06/19/1990CA1270596A1 Peptide derivatives having a nitrogenous polycyclic structure and process for their preparation
06/19/1990CA1270595A1 Imidazole derivatives, their preparation, and pharmaceuticals containing same
06/16/1990CA2005459A1 Cloning and expression of transforming growth factor beta-2
06/16/1990CA2003886A1 Cloning and expression of simian transforming growth factor-beta 1
06/15/1990CA2005476A1 Anti-tumour agents
06/14/1990WO1990006135A1 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
06/14/1990WO1990006129A1 Deletion analogues of magainin peptides
06/14/1990WO1990006119A1 Metallo-organic cobalt compounds and uses thereof
06/14/1990WO1990003798A3 Targetting agents
06/13/1990EP0372889A1 Doxorubicin solutions
06/13/1990EP0372888A1 Doxorubicin aqueous solutions
06/13/1990EP0372809A1 Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
06/13/1990EP0372707A2 Modified proteins, modified interferons, alphas and beta, phosphorylated proteins and analogues, DNA sequences, applications and uses thereof
06/13/1990EP0372409A2 Acylaminoalkylpyridineamides as inhibitors of tumor metastasis
06/13/1990EP0372268A1 Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
06/13/1990DE3841768A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841767A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841764A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841763A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841762A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841761A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841759A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841755A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841754A1 Neue tnf-peptide New tnf-peptide
06/13/1990DE3841753A1 Neue tnf-peptide New tnf-peptide
06/13/1990CN1042912A (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
06/13/1990CA2002047A1 Serineprotease inhibitor proteins, pharmaceutical compositions containing them, dna sequences coding for these proteins and processes for the preparation of these proteins, pharmaceutical compositions and dna sequences
06/12/1990US4933440 Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae
06/12/1990US4933368 N-phenylbenzamide derivatives
06/12/1990US4933357 1,3-diazolyl-2-phenylalkyl-2-propanol derivatives
06/12/1990US4932934 By injecting prophyrin aggregate, transmitting radiation hydrochloride
06/12/1990CA2005281A1 Tnf peptides
06/12/1990CA2005061A1 Tnf peptides
06/12/1990CA2005060A1 Tnf peptides
06/12/1990CA2005059A1 Tnf peptides
06/12/1990CA2005058A1 Tnf peptides
06/12/1990CA2005057A1 Tnf peptides
06/12/1990CA2005056A1 Tnf peptides
06/12/1990CA2005052A1 Tnf peptides
06/12/1990CA2005051A1 Tnf peptides
06/12/1990CA2005050A1 Tnf peptides
06/12/1990CA2004986A1 Piperidine derivatives
06/12/1990CA2004979A1 Production and use of porphyrins
06/12/1990CA1270251A1 2-(heteroalkyl)-1,4-dihydropyridines, process for their preparation and pharmaceutical compositions containing them
06/12/1990CA1270198A1 Encapsulation of antineoplastic agents in liposomes
06/12/1990CA1270197A1 Dehydrated liposomes
06/06/1990EP0371564A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives
06/06/1990EP0371543A2 Gastrin releasing peptide antagonists
06/06/1990EP0371414A2 Glycosphingolipids with a coupling group in the sphingolipid part, their preparation and use
06/06/1990EP0371137A1 Preparation for transporting radionuclides in a living organism
06/06/1990CN1042715A Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
06/06/1990CN1042658A Cytotropic non-homogeneous molecular lipid and its preparation method
06/05/1990US4931559 Optically-active isomers of dideoxycarbocyclic nucleosides
06/05/1990US4931553 Platinum-polymer complexes and their use as antitumor agents
06/05/1990US4931468 Treating malignant tumors with g-linolenic or dihomo-g-lino-lenic acid or derivatives; combined with zinc, antibiotics
06/05/1990US4931433 Method for treating certain neoplastic diseases
06/05/1990CA1269996A1 Fluorinated diaminoalkyne derivatives
06/02/1990CA2004443A1 Acylaminoalkylpyridineamides as inhibitors of metastasis
05/1990
05/31/1990WO1990005787A1 Position-specific insertion vectors and method of using same
05/31/1990WO1990005786A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
05/31/1990WO1990005747A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
05/31/1990WO1990005741A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
05/31/1990WO1990005719A1 Hydroxamic acid based collagenase inhibitors
05/31/1990WO1990005716A1 Hydroxamic acid based collagenase inhibitors
05/31/1990WO1990005539A1 Antibodies specific for elam-1 and the use thereof
05/31/1990WO1990005527A1 Inhibitors for glycosaminosyl transferase-v
05/30/1990EP0370236A1 Indolocarbazole derivatives, processes for their preparation and their use as medicaments
05/30/1990EP0370220A1 Gestode composition for transdermal application
05/30/1990EP0370052A1 Human granulocyte-macrophage colony stimulating factor and muteins thereof
05/30/1990EP0262498B1 Diamine platinum (ii) complex compounds with a hydroxy-substituted 2-phenyl-indole ring
05/30/1990EP0229128B1 Derivatives of glycero-3(2)-phospho-l-serine and pharmaceutical preparations containing them
05/30/1990EP0120054B1 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method
05/30/1990CN1042546A Antibody-drug conjugates
05/30/1990CN1042545A Application of ethylene amine tetraacetic acid as inhibitor of proteinkinase 2 or proteinkinase c for calcium/calmodulin
05/30/1990CN1042536A Chelants possessing ortho ligating functionality and complexes thereof
05/29/1990US4929607 oxazaphosphorin-4-thio alkanesulphonic acids, neutral salts thereof and method to treat cancer diseases and to produce immunosuppression
05/29/1990US4929606 Bone disorders
05/29/1990US4929601 Antitumor agents
1 ... 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 ... 2211